Calcipotriene is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Novel Laboratories, Inc.. The primary component is Calcipotriene.
Product ID | 40032-043_8661551f-77c5-401c-bbf0-bb79e047d5e1 |
NDC | 40032-043 |
Product Type | Human Prescription Drug |
Proprietary Name | Calcipotriene |
Generic Name | Calcipotriene |
Dosage Form | Solution |
Route of Administration | TOPICAL |
Marketing Start Date | 2017-12-26 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA207163 |
Labeler Name | Novel Laboratories, Inc. |
Substance Name | CALCIPOTRIENE |
Active Ingredient Strength | 0 mg/mL |
Pharm Classes | Vitamin D [CS],Vitamin D Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-12-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA207163 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-12-26 |
Ingredient | Strength |
---|---|
CALCIPOTRIENE | .05 mg/mL |
SPL SET ID: | b3b12374-e46b-4d58-8248-92787bd217bd |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0115-1475 | Calcipotriene | Calcipotriene |
0168-0400 | Calcipotriene | Calcipotriene |
0713-0318 | Calcipotriene | Calcipotriene |
0781-7117 | Calcipotriene | Calcipotriene |
16714-763 | calcipotriene | calcipotriene |
40032-043 | Calcipotriene | Calcipotriene |
50383-732 | Calcipotriene | Calcipotriene |
51407-605 | calcipotriene | calcipotriene |
51407-606 | Calcipotriene | Calcipotriene |
51672-4154 | Calcipotriene | Calcipotriene |
51862-512 | calcipotriene | calcipotriene |
66993-877 | Calcipotriene | Calcipotriene |
66993-878 | calcipotriene | calcipotriene |
68462-310 | Calcipotriene | Calcipotriene |
68462-501 | calcipotriene | calcipotriene |
51672-5278 | Calcitrene | Calcipotriene |
50222-260 | Dovonex | Calcipotriene |
51862-376 | SORILUX | calcipotriene |